Healthcare -
Biotechnology - NASDAQ - US
$ 1.3499
-6.26 %
$ 62.9 M
Market Cap
-1.25
P/E
RVPH - STOCK-BASED COMPENSATION
Stock-based Compensation RVPH - Reviva Pharmaceuticals Holdings, Inc.
3.41 M
LAST VALUE
465.56%
2 YEAR CAGR
176.67%
5 YEAR CAGR
0.00%
10 YEAR CAGR